close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Novo Nordisk CEO to step down as competition weighs on Wegovy maker's share price
Tags Europe News Breaking News: Europe Pharmaceuticals
From CNBC.com News
Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
Tags AstraZeneca PLC International: Top News And Analysis Breaking News: Politics
From CNBC.com News
Why Americans pay so much more for prescription drugs
Tags Breaking News: Politics LILLY DRN Drug Retail
From CNBC.com News
Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
Tags Biotech and Pharmaceuticals Healthy Returns Novo Nordisk A/S
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags Roche Holding AG Abbvie Inc LILLY DRN
From CNBC.com News
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
Tags Hims & Hers Health Inc Make It: Next Gen Investing Novo Nordisk A/S
From CNBC.com News
Hims & Hers brings former Amazon executive into C-suite
Tags Enterprise Breaking News: Technology Novo Nordisk A/S
From CNBC.com News
Cramer's week ahead: Earnings from Disney, Palantir and Uber
Tags DraftKings Inc Arm Holdings PLC Business News
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Amgen Inc Biotechnology Mergers
From CNBC.com News
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Tags Business Pharmaceuticals Health care industry
From CNBC.com News
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
Tags US: News Health & Science Hims & Hers Health Inc
From CNBC.com News
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
Tags LILLY DRN US: News Social issues
From CNBC.com News
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Pfizer Inc
From CNBC.com News
5 European stocks to watch this earnings season as Trump's tariffs hit
Tickers OIL
Tags AP Moeller / Maersk A/S Airlines Pharmaceuticals
From CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
Tags Breaking News: Business Biotechnology AstraZeneca PLC
From CNBC.com News
CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine
Tags NVIDIA Corp JPMorgan Chase & Co Markets
From CNBC.com News
Pfizer scraps daily weight loss pill after liver injury in one patient
Tags Breaking News: Business Biotechnology LILLY DRN
From CNBC.com News
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback
Tags Europe News Consumer Goods Business
From CNBC.com News
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
Tags Biotech and Pharmaceuticals Business News Novo Nordisk A/S
From CNBC.com News
The biggest winners and losers in Europe as Trump announces sweeping tariffs
Tags AstraZeneca PLC Pernod Ricard SA US: News
From CNBC.com News
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
Tags AstraZeneca PLC Novartis AG Bavarian Nordic A/S
From CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
Tags LILLY DRN US: News Health & Science
From CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
Tags LILLY DRN Biotech and Pharmaceuticals Biotechnology
From CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Tags Biotechnology Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
CNBC Daily Open: Consumers and CFOs alike are expecting a recession in the U.S.
Tags Microstrategy Inc Novo Nordisk A/S Markets
From CNBC.com News
CNBC Daily Open: Fears of a U.S. recession intensify among consumers and CFOs
Tags SAP AG Markets Asia Markets
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
Tags Science Health & Science Health care industry
From CNBC.com News
Software giant SAP becomes Europe's most valuable firm amid German stock market boom
Tags Breaking News: Markets Europe Markets Markets
From CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Tags Roche Holding AG Health & Science AstraZeneca PLC
From CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
Tags Pharmaceuticals Business LILLY DRN
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today